Taysha Gene Therapies, Inc. (TSHA) Balance Sheet
TSHA balance sheet, 2025
December 31, 2025 · U.S. dollars$343.3M assets = $96.4M liabilities + $246.9M equity
Both columns are drawn to the same scale: what TSHA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
TSHA financial health
Descriptive bands, not a rating. Fiscal 2025.
TSHA balance sheet trends, 2019–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $15,0002019 | $343.3M2025 | +432.8%/yr | |
| Total liabilities | $150,0002019 | $96.4M2025 | +193.8%/yr | |
| Shareholders’ equity | −$135,0002019 | $246.9M2025 | — | |
| Cash & short-term investments | $251.3M2020 | $319.8M2025 | +4.9%/yr | |
| Total debt | $63.1M2021 | $18.2M2025 | −26.7%/yr | |
| Net cash (debt) | $86.0M2021 | $301.6M2025 | +$215.6M | |
| Working capital | −$135,0002019 | $298.1M2025 | +$298.2M | |
| Book value per share | $0.652023 | $0.772025 | +9.4%/yr | |
| Debt / equity | 0.662021 | 0.072025 | −0.59 | |
| Shares outstanding | 116.1M2023 | 319.7M2025 | +65.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
TSHA assets
TSHA liabilities and equity
TSHA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
TSHA balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & short-term investments | $319.8M | $139.0M | $143.9M | $87.9M | $149.1M | $251.3M | — |
| Cash & equivalents | $319.8M | $139.0M | $143.9M | $87.9M | $149.1M | $251.3M | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $4.9M | $3.1M | $5.9M | $8.5M | $10.5M | $6.6M | $15,000 |
| Total current assets | $324.6M | $142.1M | $149.9M | $96.4M | $159.6M | $257.9M | $15,000 |
| Property, plant & equipment (net) | $16.2M | $15.9M | $20.4M | $25.9M | $50.6M | $287,000 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $2.5M | $2.4M | $2.5M | $4.0M | $3.7M | $715,000 | $0 |
| Total assets | $343.3M | $160.4M | $172.7M | $126.3M | $214.0M | $258.9M | $15,000 |
| Liabilities | |||||||
| Accounts payable | $6.3M | $3.6M | $6.4M | $10.9M | $21.8M | $2.0M | — |
| Short-term debt | — | $1.9M | $1.6M | $1.5M | — | — | — |
| Deferred revenue | — | $9.8M | $18.1M | $33.6M | — | — | — |
| Total current liabilities | $26.6M | $26.2M | $36.8M | $62.8M | $51.7M | $7.1M | $150,000 |
| Long-term debt | $50.1M | $43.9M | $40.5M | $38.0M | $37.2M | $0 | $0 |
| Lease obligations | $20.0M | $19.2M | $20.6M | $22.0M | $25.9M | $0 | — |
| Other long-term liabilities | $19.7M | $18.7M | $20.5M | $24.6M | $29.6M | $450,000 | $0 |
| Total liabilities | $96.4M | $88.8M | $97.8M | $125.3M | $118.6M | $7.6M | $150,000 |
| Shareholders' equity | |||||||
| Common stock & paid-in capital | $3,000 | $2,000 | $2,000 | $1,000 | — | — | — |
| Retained earnings (deficit) | −$711.3M | −$602.3M | −$513.0M | −$401.4M | −$235.6M | −$61.1M | −$1.1M |
| Accumulated other comprehensive income | −$192,000 | −$4.0M | $0 | $0 | — | $0 | — |
| Total shareholders' equity | $246.9M | $71.5M | $74.9M | $949,000 | $95.4M | $251.3M | −$135,000 |
| Key figures | |||||||
| Total debt | $18.2M | $63.2M | $61.1M | $59.9M | $63.1M | — | — |
| Net cash (debt) | $301.6M | $75.9M | $82.8M | $28.0M | $86.0M | — | — |
| Working capital | $298.1M | $115.9M | $113.1M | $33.6M | $107.9M | $250.8M | −$135,000 |
| Tangible book value | $246.9M | $71.5M | $74.9M | $949,000 | $95.4M | $251.3M | −$135,000 |
| Book value per share | $0.77 | $0.29 | $0.65 | — | — | — | — |
| Shares outstanding | 319.7M | 250.1M | 116.1M | — | — | — | — |
| Current ratio | 12.23 | 5.42 | 4.08 | 1.54 | 3.08 | 36.17 | 0.10 |
| Quick ratio | 12.04 | 5.30 | 3.92 | 1.40 | 2.88 | 35.24 | 0.00 |
| Debt / equity | 0.07 | 0.88 | 0.82 | 63.15 | 0.66 | — | — |
| Equity / assets | 71.9% | 44.6% | 43.4% | 0.8% | 44.6% | 97.1% | −900.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $455.4M | $276.6M | $319.8M | $297.3M | $312.8M | $116.6M | $139.0M | $157.7M | $172.7M | $124.0M | $143.9M | $164.3M |
| Cash & equivalents | $455.4M | $276.6M | $319.8M | $297.3M | $312.8M | $116.6M | $139.0M | $157.7M | $172.7M | $124.0M | $143.9M | $164.3M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $6.0M | $5.7M | $4.9M | $2.6M | $3.5M | $4.1M | $3.1M | $3.9M | $5.7M | $6.6M | $5.9M | $7.5M |
| Total current assets | $461.4M | $282.2M | $324.6M | $300.0M | $316.3M | $120.7M | $142.1M | $161.6M | $178.5M | $130.6M | $149.9M | $171.8M |
| Property, plant & equipment (net) | $8.7M | $15.6M | $16.2M | $14.3M | $14.7M | $15.3M | $15.9M | $16.3M | $19.5M | $19.9M | $20.4M | $21.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $270,000 | $2.5M | $2.5M | $2.3M | $2.3M | $2.3M | $2.4M | $2.4M | $2.4M | $2.5M | $2.5M | $2.9M |
| Total assets | $470.4M | $300.4M | $343.3M | $316.6M | $333.3M | $138.4M | $160.4M | $180.2M | $200.4M | $153.0M | $172.7M | $195.8M |
| Liabilities | ||||||||||||
| Accounts payable | $9.2M | $4.6M | $6.3M | $5.4M | $7.7M | $4.3M | $3.6M | $4.9M | $8.7M | $10.4M | $6.4M | $7.5M |
| Short-term debt | — | — | — | $1.7M | $1.7M | $1.8M | $1.9M | $1.8M | $1.8M | $1.7M | $1.6M | $1.5M |
| Deferred revenue | — | — | — | $5.5M | $5.5M | $7.5M | $9.8M | $11.8M | $13.6M | $14.7M | $18.1M | $18.8M |
| Total current liabilities | $26.0M | $20.1M | $26.6M | $28.6M | $25.3M | $22.6M | $26.2M | $29.3M | $34.2M | $38.6M | $36.8M | $180.5M |
| Long-term debt | $49.3M | $49.0M | $50.1M | $50.9M | $41.1M | $42.5M | $43.9M | $43.0M | $37.8M | $40.5M | $40.5M | $38.5M |
| Lease obligations | $7.5M | $19.6M | $20.0M | $18.2M | $18.5M | $18.9M | $19.2M | $19.6M | $19.9M | $20.2M | $20.6M | $20.6M |
| Other long-term liabilities | $7.9M | $19.3M | $19.7M | $18.1M | $18.2M | $18.3M | $18.7M | $19.1M | $19.5M | $20.0M | $20.5M | $25.9M |
| Total liabilities | $83.2M | $88.4M | $96.4M | $97.6M | $84.6M | $83.3M | $88.8M | $91.4M | $91.5M | $99.2M | $97.8M | $244.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $3,000 | $3,000 | $3,000 | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | −$800.3M | −$753.7M | −$711.3M | −$683.4M | −$650.7M | −$623.8M | −$602.3M | −$583.5M | −$558.0M | −$537.1M | −$513.0M | −$560.7M |
| Accumulated other comprehensive income | $769,000 | $985,000 | −$192,000 | −$1.1M | −$699,000 | −$2.3M | −$4.0M | −$2.3M | $2.4M | −$251,000 | $0 | — |
| Total shareholders' equity | $387.3M | $211.9M | $246.9M | $219.0M | $248.7M | $55.1M | $71.5M | $88.8M | $108.9M | $53.8M | $74.9M | −$49.1M |
| Key figures | ||||||||||||
| Total debt | $55.6M | $17.8M | $18.2M | $69.1M | $59.6M | $61.4M | $63.2M | $62.5M | $57.7M | $60.7M | $61.1M | $59.2M |
| Net cash (debt) | $399.9M | $258.8M | $301.6M | $228.3M | $253.2M | $55.2M | $75.9M | $95.2M | $115.0M | $63.3M | $82.8M | $105.1M |
| Working capital | $435.5M | $262.2M | $298.1M | $271.3M | $290.9M | $98.2M | $115.9M | $132.2M | $144.3M | $92.0M | $113.1M | −$8.6M |
| Tangible book value | $387.3M | $211.9M | $246.9M | $219.0M | $248.7M | $55.1M | $71.5M | $88.8M | $108.9M | $53.8M | $74.9M | −$49.1M |
| Book value per share | $1.05 | $0.58 | $0.77 | $0.62 | $0.83 | $0.20 | $0.35 | $0.33 | $0.47 | $0.23 | $0.40 | −$0.39 |
| Shares outstanding | 369.0M | 366.6M | 319.7M | 353.3M | 298.0M | 269.3M | 204.9M | 267.8M | 232.8M | 231.2M | 187.0M | 125.7M |
| Current ratio | 17.76 | 14.04 | 12.23 | 10.48 | 12.48 | 5.35 | 5.42 | 5.51 | 5.22 | 3.38 | 4.08 | 0.95 |
| Quick ratio | 17.53 | 13.76 | 12.04 | 10.39 | 12.34 | 5.17 | 5.30 | 5.38 | 5.05 | 3.21 | 3.92 | 0.91 |
| Debt / equity | 0.14 | 0.08 | 0.07 | 0.32 | 0.24 | 1.11 | 0.88 | 0.70 | 0.53 | 1.13 | 0.82 | — |
| Equity / assets | 82.3% | 70.6% | 71.9% | 69.2% | 74.6% | 39.8% | 44.6% | 49.3% | 54.3% | 35.2% | 43.4% | −25.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.
TSHA financial position
At the end of fiscal 2025 (December 31, 2025), Taysha Gene Therapies had total assets of $343.3 million (up 114.1% from a year earlier), total liabilities of $96.4 million and shareholders' equity of $246.9 million. It held $319.8 million in cash and short-term investments against $18.2 million of debt, a net cash position of $301.6 million. Its current ratio was 12.23. In the latest quarter (ended June 30, 2026) total assets were $470.4 million and equity $387.3 million.
Related: TSHA income statement, TSHA cash flow statement, TSHA key metrics. See the TSHA stock overview for the latest quote and news.
TSHA balance sheet FAQ
What are Taysha Gene Therapies's total assets?
Taysha Gene Therapies reported total assets of $343.3 million at the end of fiscal 2025 (December 31, 2025), compared with $160.4 million a year earlier.
How much debt does Taysha Gene Therapies have?
Taysha Gene Therapies had $18.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.07.
How much cash does Taysha Gene Therapies have?
Taysha Gene Therapies held $319.8 million in cash and short-term investments at the end of fiscal 2025; with $18.2 million of debt that is net cash of $301.6 million.
What is Taysha Gene Therapies's book value?
Taysha Gene Therapies's shareholders' equity (book value) was $246.9 million at the end of fiscal 2025, or $0.77 per share.
What is Taysha Gene Therapies's current ratio?
Taysha Gene Therapies had current assets of $324.6 million and current liabilities of $26.6 million, a current ratio of 12.23 (it can cover its short-term obligations).